SCHEMBL6479843

SCHEMBL6479843

O=C(NCCCc1cc(O)[nH]n1)c1ccc2[nH]c(-c3cc[nH]n3)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 4/20 0.39
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
FLT3 P36888 4/20 0.35
ITGB3 P05106 4/20 0.35
ITGA2B P08514 4/20 0.35
HTT P42858 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487371 0.93 ITK (0.47) ITKHDAC1HDAC2HDAC3HDAC4
SCHEMBL5755525 0.84 KDM4E (0.49) ITKHDAC1HDAC2HDAC3HDAC4
SCHEMBL5753964 0.83 KDM4E (0.46) ITKHDAC1HDAC2HDAC3HDAC4
SCHEMBL5753446 0.83 KDM4E (0.48) ITKHDAC1HDAC2HDAC3HDAC4
SCHEMBL5756790 0.81 RIPK1 (0.46) ITKHDAC1HDAC2HDAC3HDAC6
SCHEMBL5755204 0.81 HPGD (0.53) ITKFLT3HTTKDM4EALDH1A1
SCHEMBL6478732 0.80 HDAC1 (0.36) ITKHDAC1HDAC2HDAC3HDAC4
SCHEMBL5752904 0.80 ITK (0.55) ITKHDAC6KDM4EALDH1A1HPGD
SCHEMBL5755542 0.78 RIPK1 (0.44) ITKHDAC6ALDH1A1
SCHEMBL6478927 0.78 ITK (0.40) ITKHDAC1HDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 ITK 392/4885HDAC1 876/4885HDAC2 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.